Endosome function and dysfunction in Alzheimer's  disease and other neurodegenerative diseases

Author(s): Nixon RA

Abstract

Endocytosis is universally important in cell function. In the brain, the roles of endosomes are relatively more complex due to the unique polar morphology of neurons and specialized needs for inter-cellular communication. New evidence shows that endosome function is altered in a surprising range of neurodegenerative disorders, including in several inherited neurologic disorders where the causative mutations occur in genes that regulate endosome function. In Alzheimer's disease (AD), endosome abnormalities are among the earliest neuropathologic features to develop and have now been closely linked to genetic risk factors for AD, including APP triplication in Trisomy 21 (Down syndrome, DS) and ApoE4 genotype in sporadic AD. Recent findings on endosome regulation and developmental and late-onset neurodegenerative disease disorders are beginning to reveal how endocytic pathway impairment may lead to neuronal dysfunction and cell death in these disorders and may also promote amyloidogenesis in AD.

Similar Articles

Alzheimer's  disease: the challenge of the second century

Author(s): Holtzman DM, Morris JC, Goate AM

Epidemiology of  Alzheimer disease

Author(s): Reitz C, Brayne C, Mayeux R

Trafficking regulation of proteins in Alzheimer's disease

Author(s): Jiang S, Li Y, Zhang X, Bu G, Xu H, et al.

Trafficking and proteolytic processing of APP

Author(s): Haass C, Kaether C, Thinakaran G, Sisodia S

Efficient inhibition of the Alzheimer's disease  beta-secretase by membrane targeting

Author(s): Rajendran L, Schneider A, Schlechtingen G, Weidlich S,  Ries J, et al.

Crystal structure of an active form of BACE1, an enzyme responsible for  amyloid beta protein production

Author(s): Shimizu H, Tosaki A, Kaneko K, Hisano T, Sakurai T, et al. 

Aβ-degrading enzymes: potential for treatment of Alzheimer disease

Author(s): Miners JS, Barua N, Kehoe PG, Gill S, Love S

Nonsteroidal anti-inflammatory drugs repress beta-secretase gene  promoter activity by the activation of PPARgamma

Author(s): Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E,  et al.

Cholesterol reduction impairs exocytosis of synaptic vesicles

Author(s): Linetti A, Fratangeli A, Taverna E, Valnegri P, Francolini  M, et al.

Critical time window of neuronal cholesterol  synthesis during neurite outgrowth

Author(s): Fünfschilling U, Jockusch WJ, Sivakumar N, Möbius W,  Corthals K, et al.

Cholesterol  homeostasis in neurons and glial cells

Author(s): Vance JE, Hayashi H, Karten B

Lipoproteins and their receptors in the central nervous system

Author(s): Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH